(A) A cohort (n=70) of patients chronically infected with HIV-1 clade B or clade C were screened for the presence of high titers of antibodies able to neutralize a panel of nine HIV-1 PVs from the Global Panel of HIV-1 reference strains. The sera were tested in neutralization assay using TZMbl cells and the ID50s (y-axes) were determined.
(B) Identification of LN01 mAb. IgG GC and IgG memory B cells isolated from LNMC of an HIV-1 infected donor were seeded on MSC at 3 c/well in 384-well plates in the presence of IL-2, IL-6, IL-21, BCR-trigger and EBV. After 14 days of culture, supernatants were collected and tested for their ability to neutralize HIV-1 strains CE1176 and BJOX PV using a TZMbl-base micro-neutralization assay. 
Figure S7 related to Figures 1D and E: Binding of LN01 variants to gp41 MPER-TM2 as measured by Bio-layer interferometry (BLI). Colored lines represent the response curves
(blue is the lowest concentration and purple the highest). For LN01 sH/sL, LN01 gH/sL and LN01 sH/gL-FR the red line represents the best fit (1:1 model, see STAR*METHODS).
Table S1 related to Figures 2A, B. Breadth, and potency of LN01 mAb against 118 HIV-1 PVs. LN01 and 10E8 were tested in micro-neutralization assay on TZM-bl target cells against the extended panel of 118 HIV-1 PVs. Shown are the IC50 and IC80 values. Color code: red < 1 µg/ml; orange 1-10 µg/ml; yellow > 10 µg/ml. 
